Pennsylvania health centers are upset about what they say was the state Medicaid office’s disclosure without warning last week that, starting July 1, it wants drug claims billed to Medicaid managed care organizations to include a modifier showing if the prescription was filled with a 340B-purchased drug. The Medicaid office says the change is needed to stop drug manufacturers from being improperly invoiced for rebates on 340B-purchased drugs.
Health centers say if the state implements its proposed requirement, they effectively will be unable to dispense 340B-purchased drugs to Medicaid MCO beneficiaries, leading to major revenue losses and cuts in patient services. Pennsylvania Department of Human Services officials are scheduled to brief the state Medicaid advisory committee about the proposed change during a committee meeting Thursday.
Pennsylvania health centers are upset about what they say was the state Medicaid office’s disclosure without warning last week that, starting July 1, it wants drug claims billed to Medicaid managed care organizations to include a modifier showing if the […]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
